Molecular Lipopolysaccharide Di-Vaccine Protects from Shiga-Toxin Producing Epidemic Strains of Escherichia coli O157:H7 and O104:H4

por Dyatlov, Ivan A., Svetoch, Edward A., Mironenko, Anna A., Eruslanov, Boris V., Firstova, Victoria V., Fursova, Nadezhda K., Kovalchuk, Alexander L., Lvov, Vyacheslav L., Aparin, Petr G.
Publicado 2022

Characterization of the adaptive immune response of donors receiving live anthrax vaccine

por Firstova, Victoria V., Shakhova, Anastasia S., Riabko, Alena K., Silkina, Marina V., Zeninskaya, Natalia A., Romanenko, Yana O., Marin, Maksim A., Rogozin, Methun M., Kartseva, Alena S., Dyatlov, Ivan A., Shemyakin, Igor G.
Publicado 2021

Is It Possible to Create Antimicrobial Peptides Based on the Amyloidogenic Sequence of Ribosomal S1 Protein of P. aeruginosa?

por Grishin, Sergei Y., Domnin, Pavel A., Kravchenko, Sergey V., Azev, Viacheslav N., Mustaeva, Leila G., Gorbunova, Elena Y., Kobyakova, Margarita I., Surin, Alexey K., Makarova, Maria A., Kurpe, Stanislav R., Fadeev, Roman S., Vasilchenko, Alexey S., Firstova, Victoria V., Ermolaeva, Svetlana A., Galzitskaya, Oxana V.
Publicado 2021